Sandbox:MDS: Difference between revisions

Revision as of 15:59, 7 December 2015


Name	Description

Refractory anemia	Less than 5% primitive blood cells (myeloblasts) in the bone marrow and pathological abnormalities primarily seen in red cell precursors.
Refractory anemia with ring sideroblasts	Less than 5% myeloblasts in the bone marrow, but distinguished by the presence of 15% or greater red cell precursors in the marrow being abnormal iron-stuffed cells called ringed sideroblasts.
Refractory anemia with excess blasts	5-20% myeloblasts in the marrow.
Refractory anemia with excess blasts in transformation	21-30% myeloblasts in the marrow (>30% blasts is defined as acute myeloid leukemia).
Chronic myelomonocytic leukemia	Less than 20% myeloblasts in the bone marrow and greater than 1*109/L monocytes in peripheral blood.

@@ Line 19: / Line 19: @@
 | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Refractory anemia with excess blasts'''|| style="padding: 5px 5px; background: #F5F5F5;"|
-:* 5-20% myeloblasts in the marrow
+:* 5-20% myeloblasts in the marrow.
 |-
 | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Refractory anemia with excess blasts in transformation'''|| style="padding: 5px 5px; background: #F5F5F5;" |
-:*21-30% myeloblasts in the marrow (>30% blasts is defined as acute myeloid leukemia)
+:*21-30% myeloblasts in the marrow (>30% blasts is defined as acute myeloid leukemia).
 |-